China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Net Income From Continuing Operations : ¥1,347 Mil (TTM As of Mar. 2024)

View and export this data going back to 1997. Start your Free Trial

What is China Resources Double-Crane Pharmaceutical Co Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. China Resources Double-Crane Pharmaceutical Co's net income from continuing operations for the three months ended in Mar. 2024 was ¥405 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1,347 Mil.

China Resources Double-Crane Pharmaceutical Co Net Income From Continuing Operations Historical Data

The historical data trend for China Resources Double-Crane Pharmaceutical Co's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Resources Double-Crane Pharmaceutical Co Net Income From Continuing Operations Chart

China Resources Double-Crane Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income From Continuing Operations

Get a 7-Day Free Trial

1,066.46

1,013.50

972.13

1,233.65

1,325.91

China Resources Double-Crane Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Income From Continuing Operations	Get a 7-Day Free Trial															383.33	401.84	287.93	252.80	404.71

China Resources Double-Crane Pharmaceutical Co Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,347 Mil.

China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) » Definitions » Net Income From Continuing Operations

Traded in Other Exchanges

N/A

Address

No. 1, East Second Road, Lijing, Wangjing, Chaoyang District, Beijing, CHN, 100102

Website

http://www.dcpc.com

China Resources Double-Crane Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is engaged in developing, manufacturing and marketing a variety of medical products. The company's products cover different fields such as infusion field, cardiovascular and cerebrovascular fields, pediatrics, endocrine field and other areas.

China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Headlines

No Headlines